Medicinal substances are often combined with a medical device intended for delivery. These devices include pre-filled syringes, pre-filled pens, nebulizers pre-charged with a specific medicinal product etc. The EU’s Medical Device Regulation (MDR) introduces MDR Article 117 with the purpose is to ensure compliance of such devices with the relevant general safety and performance requirements set out in Annex I of the MDR regulation. Manufacturers are required to involve a Notified Body such as TÜV SÜD to assess manufacturers documentation / dossier and to confirm such product compliance to GSPRs.
From 26 May 2021, new marketing authorization applications for medicinal products with an integral medical device shall be accomplished by a notified body opinion report, where CE mark or a declaration of conformity for the medical device is missing. During preparation steps towards marketing application, it is important to be informed about the requirements and deadlines to obtain a notified body opinion report for the device part of the medicinal product.
Notified Body Opinion: Key Steps for Manufacturers
A Notified Body Opinion is a report which documents the result of the assessment on the device's conformity with the relevant GSPR as set out in Annex I of the MDR. Manufacturer’s documentation is assessed by an MDR-designated Notified Body such as TÜV SÜD, for suitability of a device for its intended purpose, considering complexity of the device, relevant patient characteristics and the clinical setting. Having your documentation assessed by an MDR-designated Notified Body provides an independent report on the technical documentation following the legislative framework.